Top Stories
-
A new gene editor developed by Columbia and Broad Institute researchers may soon open the door to gene therapies for a wider array of diseases.
Topic
-
Millions of people with fatty liver disease do not know they have it. Columbia researchers are developing technology that mines electronic health records to find them.
Topic
-
Through a trial offered at Columbia, a patient who is ineligible for existing treatments is the first to receive an experimental gene therapy.
Topic
-
Columbia researcher Orson Xu envisions harnessing AI to analyze data from phones and wearable devices to provide people with insights into potential health concerns and enable real-time interventions.
Topic
Latest News
- January 21, 2025
Advances in bioengineering at Columbia may enable delivery of gene therapies for people with cystic fibrosis and other lung diseases.
Topic
- December 18, 2024
Future treatments for hearing loss—including gene therapy—could come to rely on a tiny 3D-printed microneedle designed by a close-knit team of Columbia physicians and engineers.
Topic
- October 16, 2024
Columbia researchers have engineered bacteria as personalized cancer vaccines that activate the immune system to specifically seek out and destroy cancer cells.
Topic
- September 4, 2024
Columbia researchers have used blockchain technology to build a system that can securely store, share, and analyze genetic and clinical data for precision medicine research.
Topic
- August 8, 2024
A “loopy” discovery in bacteria is raising fundamental questions about the makeup of our own genome. And revealing a potential wellspring of material for new genetic therapies.
Topic
- July 26, 2024
The first guidelines for genetic testing of people with chronic kidney disease recommend genetic testing for many patients.
Topic
- June 6, 2024
Researchers at Columbia University College of Dental Medicine have engineered exosomes to carry CRISPR, significantly enhancing the delivery of genome editing components to specific cells and tissues.
Topic
- May 16, 2024
In the lab, Aimee Payne, Columbia’s new chair of dermatology, is transforming cells into living drugs for autoimmune diseases of the skin.
Topic
- March 8, 2024
Columbia MD/PhD student Deirdre Ricaurte is using new genomics methods to understand how prescription drugs disturb our gut microbiome and the health consequences of these “drug-bug” interactions.
Topic
- December 11, 2023
Many Black Americans thought to have a high risk of developing kidney disease possess a genetic variant that eradicates the extra risk, a new study from Columbia researchers has found.
Topic
